Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury.
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Sepsis-induced lung injury is a persisting clinical problem with no direct therapy. Recent work suggests that intravenously infused ascorbic acid improves the circulatory dysfunction of sepsis. We used a model of endotoxin-induced acute lung injury to determine whether parenteral ascorbic acid modulates the dysregulated proinflammatory, procoagulant state that leads to lung injury. DESIGN: C57BL/6 mice were exposed to lethal lipopolysaccharide doses (10 μg/g of body weight) to induce acute lung injury. SETTING: Laboratory investigation. SUBJECTS: Wild-type C57BL/6 mice. INTERVENTIONS: Ascorbic acid or its oxidized form (dehydroascorbic acid) was administered intraperitoneally at 200 mg/kg 30 mins after the lethal lipopolysaccharide dose. MEASUREMENTS AND MAIN RESULTS: We quantified survival, lung capillary leak, proinflammatory chemokine expression, and lung microvascular thrombosis. Lipopolysaccharide induced 100% lethality in mice within 28 hrs of exposure and in lung we observed intense neutrophil sequestration, loss of capillary barrier function, exuberant pulmonary inflammation, and extensive microthrombus formation. A time-delayed infusion protocol of both ascorbic acid and dehydroascorbic acid significantly prolonged survival. Both ascorbic acid and dehydroascorbic acid preserved lung architecture and barrier function while attenuating proinflammatory chemokine expression and microvascular thrombosis. Ascorbic acid and dehydroascorbic acid attenuated nuclear factor kappa B activation and normalized coagulation parameters. CONCLUSIONS: Ascorbic acid administered in an interventional manner following lipopolysaccharide infusion attenuates proinflammatory, procoagulant states that induce lung vascular injury in an animal model of sepsis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Vitamin C increased alveolar fluid clearance by preventing activated neutrophil accumulation in alveolar spaces, limiting alveolar epithelial water-channel damage, and promoting their increased expression.14”
In the citing paper
“Preclinical research in early sepsis revealed that vitamin C prevented sepsis-induced cytokine surges that activate and sequester neutrophils in lung, thus damaging alveolar capillaries.13,14”
Citations
Cites
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742 · cited 1×
“Furthermore, it is generally agreed that it is not the bacterial infection itself, but rather the inflammatory response to infection that is the predominant determinant of outcomes in sepsis (25, 26).”
BackgroundHMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line
Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C., & Lawley, T. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12613748 · Cited by 1,265 · cited 1×
“The human microvascular endothelial cell line HMEC-1 was obtained from the Centers for Disease Control and Prevention (Atlanta, GA) (15) and cultured as described in the online supplement (Supplemental Digital Content 1, http:// links.”
MethodSepsis: A New Hypothesis for Pathogenesis of the Disease Process
Bone, R. C., Grodzin, C. J., & Balk, R. A. (1997) · Chest · doi:10.1378/chest.112.1.235 · Cited by 1,021
Chen, Q., Espey, M. G., Sun, A. Y., Pooput, C., Kirk, K. L., Krishna, M. C., Khosh, D. B., Drisko, J., & Levine, M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804226105 · Cited by 854 · cited 1×
“Although AscA can also be a pro-oxidant, generating hydrogen peroxide-dependent cytotoxicity toward cancer cells without affecting normal cells, the doses of AscA required for its pro-oxidant effects are several-fold higher than those used in the current study (39).”
BackgroundNishikimi, M., Fukuyama, R., Minoshima, S., Shimizu, N., & Yagi, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36884-9 · Cited by 503 · cited 1×
“Ascorbic acid (AscA) is an essential vitamin for humans who lack L-gulono-lactone oxidase, the final enzyme in the biosynthetic pathway for AscA (8).”
BackgroundMatthay, M. A., Zimmerman, G. A., Esmon, C., Bhattacharya, J., Coller, B., Doerschuk, C. M., Floros, J., Gimbrone, M. A., Hoffman, E., Hubmayr, R. D., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-966ws · Cited by 496
A new recommended dietary allowance of vitamin C for healthy young women
Levine, M., Wang, Y., Padayatty, S. J., & Morrow, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171318198 · Cited by 496 · cited 1×
“Although AscA circulates in human plasma at approximately 30–50 M, it accumulates in millimolar concentrations in host defense cells (11).”
BackgroundMammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid
Vera, J. C., Rivas, C. I., Fischbarg, J., & Golde, D. W. (1993) · Nature · doi:10.1038/364079a0 · Cited by 496
Mechanisms of sepsis-induced organ dysfunction
Abraham, E., & Singer, M. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000282072.56245.91 · Cited by 442
Research works printed but not linked: 2
- Knowles, 2003, Cancer Res, 63, 1764
- Lehr, 2006, Eur J Med Res, 11, 516
Cited by
Items 101–175 of 175
The Variable Nature of Vitamin C—Does It Help When Dealing with Coronavirus?
Grudlewska‐Buda, K., Wiktorczyk-Kapischke, N., Budzyńska, A., Kwiecińska-Piróg, J., Przekwas, J., Kijewska, A., Sabiniarz, D., Gospodarek-Komkowska, E., & Skowron, K. (2022) · Antioxidants · doi:10.3390/antiox11071247 · Cited by 13
Marik, P. E. (2018) · Surgical Infections · doi:10.1089/sur.2018.111 · Cited by 14
“In experimental models, parenteral vitamin C attenuates organ injury and improves survival in mice with sepsis [92–94].”
Masood, H., Burki, A. M., Sultan, A., Sharif, H., Ghauri, A., Khan, S., Qureshi, M. S. S., Qadeer, A., & Rasheed, G. (2019) · Cureus · doi:10.7759/cureus.5016 · Cited by 14
Zhang, C., Zhao, Y., & Yang, X. (2021) · Immunologic Research · doi:10.1007/s12026-021-09240-1 · Cited by 13
Rasheed, M., Simmons, G. L., Fisher, B., Leslie, K. A., Reed, J. C., Roberts, C. H., Natarajan, R., Fowler, A. A., & Toor, A. A. (2019) · European Journal Of Haematology · doi:10.1111/ejh.13287 · Cited by 13
Self-citationKawade, N., Tokuda, Y., 辻野, 祥., Aoyama, H., Kobayashi, M., Murai, A., & Horio, F. (2018) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.64.404 · Cited by 13
Clinical course of COVID-19 patients treated with ECMO: A multicenter study in Daegu, South Korea
Jang, W. S., Kim, J.-B., Baek, J. H., Jung, H., Jang, J. S., Park, J. S., Oh, T.-H., Jang, S. Y., Kim, Y. S., & Kwon, Y. S. (2020) · Heart & Lung · doi:10.1016/j.hrtlng.2020.10.010 · Cited by 14
Intravenous Ascorbic Acid and Lung Function in Severely Ill COVID-19 Patients
Sokary, S., Ouagueni, A., & Ganji, V. (2022) · Metabolites · doi:10.3390/metabo12090865 · Cited by 13
“Because ascorbic acid has immunomodulatory [30], anti-inflammatory [31], and antioxidant properties [32], this vitamer has been studied for its potential role in the prevention and treatment of multiple viral diseases, including COVID-19 [33–36].”
BackgroundLauer, A., Burkard, M., Niessner, H., Leischner, C., Renner, O., Vollbracht, C., Michels, H., Busch, C., Sinnberg, T. W., & Venturelli, S. (2021) · Nutrients · doi:10.3390/nu13072366 · Cited by 13
Mohamed, H. A., Elbastawisy, Y. M., & Elsaed, W. M. (2019) · SAGE Open Medicine · doi:10.1177/2050312119828260 · Cited by 12
Intravenous vitamin C for vasoplegia: A double-blinded randomised clinical trial (VALENCIA trial)
Anstey, M., Aljeaidi, M. S., Palmer, R. N., Jacques, A., Mevavala, B. V., Litton, E., & Wibrow, B. A. (2023) · Journal of Critical Care · doi:10.1016/j.jcrc.2023.154369 · Cited by 10
Al-Mayyahi, R. S., & Al-Tumah, W. A. G. (2021) · Iraqi Journal of Pharmaceutical Sciences · doi:10.31351/vol30iss1pp56-65 · Cited by 11
Vitamins C and E protect from sepsis-induced lung damage in rat and CT correlation
Canbolat, N., Özkul, B., Sever, İ. H., Söğüt, İ., Eroğlu, E., Uyanıkgil, Y., & Erbaş, O. (2022) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2022_132 · Cited by 10
Donovan, K., Shah, A., Day, J., & McKechnie, S. (2021) · Anaesthesia · doi:10.1111/anae.15369 · Cited by 11
“Interest in vitamin C as an adjunctive treatment for sepsis dates back several decades, but there is increasing evidence of biological plausibility from pre-clinical studies [37, 38].”
BackgroundAny Role of High-Dose Vitamin C for Septic Shock in 2021?
Agarwal, A., Hager, D. N., & Sevransky, J. (2021) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0041-1733986 · Cited by 9
Update on vitamin C administration in critical illness
Fujii, T., Lankadeva, Y. R., & Bellomo, R. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000951 · Cited by 10
“pulmonary architecture and endothelial barrier function by attenuating the activation of nuclear factor kappa B, chemokine expression and microvascular thrombosis [29].”
BackgroundEffect of intravenous vitamin C on adult septic patients: a systematic review and meta-analysis
Liang, H., Mu, Q., Sun, W., Liu, L., Qiu, S., Xu, Z., Cui, Y., Yan, Y., & Sun, T. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1211194 · Cited by 10
“This also depends on the effect of VC promoting alveolar epithelial waterchannel expression and preventing damage (11).”
BackgroundWong, D. M., Young, L. R., & Dembek, K. A. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16188 · Cited by 10
Profil Penggunaan Obat pada Pasien COVID-19 di Rumah Sakit Umum Daerah Ulin Banjarmasin
Ariyani, H., Fitriani, S. W., & Rahmah, S. (2021) · Jurnal Pharmascience · doi:10.20527/jps.v8i2.11144 · Cited by 11
Jackson, K. E., & Semler, M. W. (2022) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.05.003 · Cited by 11
Xu, Y., Xu, C.-Z., Liang, Y., Jin, D., Ding, J., Sheng, Y., Zhang, L., & Deng, F. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2082978 · Cited by 7
“Moreover, AscA at a high dose (200mg/kg) displayed some protective effects on LPS-induced organ injury, such as lung, kidney, and liver [19,23].”
BackgroundWang, L., Li, B., Zuo, L., Pei, F., Nie, Y., Liu, Y.-J., Liu, Z., Wu, J., & Guan, X. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.02.005 · Cited by 7
Safety of High-Dose Vitamin C in Critically Ill Patients: A Systematic Review and Meta-analysisPreprint
Shrestha, D. B., Budhathoki, P., Sedhai, Y. R., Mandal, S. K., Shikhrakar, S., Karki, S., Baniya, R. K., Kashiouris, M. G., Qiao, X., & Fowler, A. A. (2021) · Research Square · doi:10.21203/rs.3.rs-766215/v1 · Cited by 7
Self-citationMatsuoka, T., Shinozaki, H., Ozawa, S., Izawa, Y., Koyanagi, K., Lefor, A. K., & Kobayashi, K. (2019) · Annals of Thoracic and Cardiovascular Surgery · doi:10.5761/atcs.oa.19-00202 · Cited by 7
The effect of vitamin C on plasma volume in the early stage of sepsis in the rat
Bark, B. P., & Grände, P. (2014) · Intensive Care Medicine Experimental · doi:10.1186/2197-425x-2-11 · Cited by 5
“While previous studies have shown beneficial effects of vitamin C, such as reduced transcapillary leakage, reduced lymph flow and reduced oedema formation, using the same treatment regimes that were used in the present study [4,6,9,10], we could not demonstrate any effects on the plasma volume loss.”
BackgroundMethodInfluentialZhao, B., Sun, W., Wang, Y., Ma, L., Gui, M., Li, J., Qi, X., Qi, X., Ning, N., Sun, S., et al. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01437-z · Cited by 4
“This effect was also observed in septic models [22].”
Kim, Y., Ko, B. S., Roh, Y., Kim, Y. H., & Kim, W. Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319733 · Cited by 4
“Theoretical and experimental studies suggested that the concomitant use of cortisol, thiamine, and ascorbic acid might have potential treatment synergism for whole-body ischemia/reperfusion injuries after cardiac arrest [12–14].”
Current Practice Review in the Management of Acute Respiratory Distress Syndrome
Chudow, M. B., Condeni, M. S., Dhar, S., Heavner, M. S., Nei, A. M., & Bissell, B. D. (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900221108713 · Cited by 4
Vitamin C biochemistry: From scurvy to COVID-19 treatment
Zakić, T., Soskic, M. B., Kalezic, A., Korać, A., Janković, A., & Korać, B. (2020) · Hrana i ishrana · doi:10.5937/hraish2002059z · Cited by 4
Smaha, J., Kužma, M., Jackuliak, P., & Payer, J. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.146 · Cited by 4
“Deficit aj iných minerálov a stopových prvkov so známym vplyvom na imunitný systém, napríklad deficit vitamínu C, selénu, či zinku sa môže tiež podieľať na zvýšenej prevalencii respiračných infekcii počas zimných mesiacov (29, 30).”
Osier, W., Nozik‐Grayck, E., & Sul, C. (2026) · Antioxidants · doi:10.3390/antiox15020249 · Cited by 3
“In preclinical investigations using endotoxin-induced models of acute lung injury and sepsis, treatment with vitamin C decreased inflammatory and prothrombotic responses, attenuated lung vascular injury, and improved survival [193].”
The Role of Neutrophils and NETosis in Diseases: The Implications for Therapy
Ma, Z., Wang, Q., Zhang, Y., Li, Y., Wu, H., Yang, H., & Li, X. (2026) · MedComm · doi:10.1002/mco2.70770 · Cited by 4
Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
Zhang, D., Wang, L., Wang, Z., Shi, X., Tang, W. H., Jiang, L., Yi, B. Y. C. H. B. R., Lv, X., Hu, C., & Xiao, D. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0551 · Cited by 4
“[16] showed that VitC significantly attenuated the expression of proinflammatory chemokines and NF-kB activity in septic mice and prolonged their survival time.”
BackgroundLimitations in the Design of Critical Care Studies and Suggestions for Future Research Directions
Meduri, G. U., Lanini, S., & Smit, J. M. (2026) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2762-8278 · Cited by 4
“Collectively, these ndings highlight an opportunity for future research to explore strati ed trial designs that consider biological heterogeneity, incorporate dynamic biomarker monitoring, and evaluate phase-speci csupplementationstrategies inconjunction”
Vitamin C deficiency in critically ill COVID-19 patients admitted to intensive care unit
Chiscano‐Camón, L., Ruiz‐Rodríguez, J. C., Plata-Menchaca, E. P., Martin, L., Bajaña, I., Martin-Rodríguez, C., Palmada, C., Ferrer, R., Camós, S., Villena-Ortiz, Y., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1301001 · Cited by 4
“It has been hypothesized that vitamin C could mitigate the inflammatory cascade in ARDS patients (6, 29–31).”
BackgroundWilson, J. X. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_62 · Cited by 3
Lines of Treatment of COVID-19 Infection
ElGoly, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90595-4.00002-9 · Cited by 3
Ceylan, T., Akın, A. T., Kaymak, E., Varinli, Ş., & Toluk, A. (2024) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.1233245 · Cited by 2
The critical care literature 2019
Winters, M. E., Hu, K. M., Martinez, J. P., Mallemat, H. A., & Brady, W. J. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.09.059 · Cited by 3
Витамин С при критических состояниях: от эксперимента к клинике (часть 1)
Чуклін, С. М., & Chuklin, S. S. (2021) · EMERGENCY MEDICINE · doi:10.22141/2224-0586.16.7-8.2020.223713 · Cited by 2
Michailides, C., & Velissaris, D. (2021) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2021.1808 · Cited by 2
Vitamin C and corticosteroids in viral pneumonia
Anstey, M., Luu, J., Myers, E., Palmer, R. N., Wibrow, B. A., & Ho, K. M. (2021) · Acute and Critical Care · doi:10.4266/acc.2020.01081 · Cited by 2
“Dear Editor: The current coronavirus disease 2019 (COVID-19) pandemic has re-ignited interest in using adjunctive agents—including corticosteroids and vitamin C—to attenuate the severity of viral pneumonia and acute lung injury [1,2].”
BackgroundSulaiman, K. A. A., Juhani, O. A., Salah, K. B., Badreldin, H. A., Harthi, A. A., Alenazi, M., Alharbi, A. A., Algarni, R., Harbi, S. A. A., Alhammad, A., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-354711/v1 · Cited by 2
Vitamin C for sepsis: Questions remain
Fujii, T., Udy, A. A., & Lankadeva, Y. R. (2022) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2022.101151 · Cited by 3
Cerebellar abiotrophy in a quarter horse foal
Primo, A. L. M., Assis, D. M., Santos, V. G. S., de Melo, L. R. B., da Nóbrega, L. D., Dantas, A. F. M., & Maciel, T. A. (2025) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2025.105386 · Cited by 1
Yüksel, R. C., Yildirim, F., Kıraklı, C., Temel, Ş., Güzeldağ, S., Gullu, Z., EREN, E. E., Şimşek, M., Sipahioğlu, H., İnci, K., et al. (2023) · Journal of Critical and Intensive Care · doi:10.37678/dcybd.2023.3215 · Cited by 1
Yeşildal, F., & İşman, F. K. (2020) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2020-0237 · Cited by 5
“Ascorbic acid (AA), known with its antioxidant characteristics, was found to have a protective effect on alveolar capillaries in patients with sepsis [2].”
BackgroundVitamin C: Current Concepts in Human Physiology
Carr, A. C., & Natarajan, R. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-295-2 · Cited by 1
Self-citationVitamin C (l-ascorbic acid) in brain injury
Leichtle, S. W., Almohaish, S., Sandler, M., Yajnik, V., Rivet, D. J., Kashiouris, M. G., Fowler, A. A., & Brophy, G. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89835-5.00040-5 · Cited by 1
Self-citationMahmoodpoor, A., Shadvar, K., Sanaie, S., Hadipoor, M. R., Pourmoghaddam, M. A., & Saghaleini, S. H. (2020) · Research Square · doi:10.21203/rs.3.rs-46003/v2 · Cited by 1
Galley, H. F. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182185694
8. Vitamin C, scurvy, inflammation and cancer
Maltos, A. L., Portari, G. V., & da Cunha, D. F. (2016) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-822-3_8
The closed-loop pathways of signaling moleculesPreprint
Liu, Y. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/129841
“infections, and plays a role on preventing and treating pneumonia [33] and other lung disease [34].”
Backgroundinduced acute lung injury by ascorbic acid Mechanisms of attenuation of abdominal sepsis
Natarajan, R., Wegelin, A., Brophy, D. F., Ward, K. R., Voelkel, N. F., Fowler, A. A., Fisher, B., Martin, E. J., & Farkas, D. (2012)
Self-citationНаучное обоснование применения аскорбиновой кислоты у больных с термической травмой
Lytovchenko, A., Олейник, Г. А., & Lytovchenko, Y. Y. (2019) · EMERGENCY MEDICINE · doi:10.22141/2224-0586.4.99.2019.173948 · Cited by 1
Étude CITRIS-ALI : comment un résultat principal peut dissimuler un résultat majeur
Marik, P. E., & Payen, D. M. (2019) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2019.11.022
Fujii, T., & Udy, A. A. (2021) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2021.100806
Dermatological manifestations of COVID-19 and its therapies: a review
Singdia, H., Mathur, R., Nijhawan, S., Rani, N., Kothari, D., Garg, R., Bhargava, P., & Mathur, D. K. (2021) · International Journal of Research in Dermatology · doi:10.18203/issn.2455-4529.intjresdermatol20210590
“SARS-CoV2 binds to ACE2 by spike protein (S) and this allows entry of virus inside the cell.(41) In order for virus to complete entry into the cell following this initial process, the spike protein has to be primed by a protease (TMPRSS2) to complete this process.”
BackgroundВитамин С при критических состояниях: от эксперимента к клинике (часть 2)
Чуклін, С. М., & Chuklin, S. S. (2021) · EMERGENCY MEDICINE · doi:10.22141/2224-0586.17.1.2021.225708
Kashiouris, M. G. (2021) · Research Square · doi:10.21203/rs.3.rs-764236/v1
Loomis, K. H., Rockwell, C. E., Sternard, H., & Novy, R. E. (2007) · Journal of Biomolecular Techniques JBT
Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury: Erratum
(2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318227739a
Mahmoodpoor, A., Shadvar, K., Sanaie, S., Hadipoor, M. R., Pourmoghaddam, M. A., & Saghaleini, S. H. (2020) · Research Square · doi:10.21203/rs.3.rs-46003/v1
COVID-19: Management of mild-moderate disease
Condoluci, M., Fussa, M., & Glowacki, J. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91812-1.00012-3
İnan, A., & Bölükçü, S. (2023) · Cam and Sakura Medical Journal · doi:10.4274/csmedj.galenos.2022.2022-12-1
Bayraktar, S., Karaböcüoğlu, M., Nayır, A., Yıldırı, Z. Y., Karapınar, B., Yazıcı, P., Ağın, H., Ceylan, G., Çıtak, A., Göncü, S., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1564
Ascorbic acid and thiamine as adjunctive therapy for ovine pneumonia
Massoudi, A., Jalilzadeh‐Amin, G., Dalir‐Naghadeh, B., & Asri‐Rezaei, S. (2024) · Small Ruminant Research · doi:10.1016/j.smallrumres.2024.107293 · Cited by 1
Galali, Y., Davies, S. J., Balaky, H. H., & Jabbar, A. (2024) · Journal of university of Anbar for pure science · doi:10.37652/juaps.2023.144371.1161 · Cited by 1
Ascorbate for Organ Dysfunction in Critically Ill Patients With Sepsis
Files, D. C., Matthay, M. A., Ware, L. B., Brower, R. G., Aggarwal, N. R., Brown, S. M., Chang, S. Y., Douglas, I. S., Duggal, A., Gibbs, K. W., et al. (2025) · CHEST Critical Care · doi:10.1016/j.chstcc.2025.100168
Self-citationSun, W., Deng, L., Zou, W., Wei, P., Hao, S., Wu, H., Lü, W., & He, Y. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1620128
“Vitamin C administration displayed some protective effects on LPS-induced liver injury with a level at 200 mg/ kg BW (29) and reversed hepatotoxicity at 5 mg/mL when combined with niacinamide (30).”
Protective Effects of Liposomal Vitamin C on SARS-CoV-2 Target Viral Entry Genes in Renal Cells
Behmardi, A., Zolghadr, L., Rajaei, F., Khoei, S. G., & Gheibi, N. (2025) · Reports of Biochemistry and Molecular Biology · doi:10.61882/rbmb.13.4.484
Amir, A., Minhas, M., Beyene, E., Ononenyi, C., Deverapalli, M., & Michael, M. B. (2026) · Journal of the National Medical Association · doi:10.1016/j.jnma.2026.03.007
Xie, F., Sun, Y., Wei, X., Zhang, W., Luo, W., Huang, J., Fang, S., Zhang, X., Qiu, H., & Chao, J. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3274-2
“Importantly, intratracheal delivery of AA in murine models achieved greater targeting efficiency than did systemic administration (Fisher et al., 2012; Fisher et al., 2011), enabling direct access to inflamed pulmonary compartments.”
Dumargne, H., Ly, S. H., Louzier, V., Allaouchiche, B., Hammed, A., & Dargent, A. (2026) · Critical Care · doi:10.1186/s13054-026-06160-0
Biased editorial on vitamin C in JAMA by Brant and Angus (2019)
Hemilä, H. (2020) · doi:10.5281/zenodo.20157034 · Cited by 1
Metadata
- Authors
- Fisher, B. J., Seropian, I. M., Kraskauskas, D., Thakkar, J. N., Voelkel, N. F., Fowler, A. A., & Natarajan, R.
- Affiliations
- Virginia Commonwealth University (US)
- Venue
- Critical Care Medicine
- Published
- 2011-06
- Volume
- 39
- Issue
- 6
- Pages
- 1454-1460
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2049662677
- Semantic Scholar
- 1f52e6c58de575dfb35a1e6237c09ee37f453e6e
- Cited by
- 178
- References
- 43
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 6 · 2023: 13 · 2022: 16 · 2021: 40 · 2020: 30 · 2019: 15 · 2018: 10 · 2017: 10 · 2016: 4 · 2015: 3 · 2014: 7 · 2013: 5 · 2012: 2
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Keywords
- vitamin C, dehydroascorbic acid, acute lung injury, sepsis, lipopolysaccharide, endotoxemia, NF-κB activation, coagulation, neutrophil sequestration, chemokine expression, lung barrier function, survival
- MeSH terms
- Animals, Antioxidants, Ascorbic Acid, Disease Models, Animal, Escherichia coli, Lipopolysaccharides, Male, Mice, Inbred C57BL, Sepsis, Mice, Acute Lung Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.